drugset / Trial / NCT07284745
A Study of KarXT + KarX-EC for Treatment of Irritability in Children and Adolescents With Autism
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to assess KarXT + KarX-EC for the treatment of irritability associated with autism in children and adolescents.
Timeline
- Start
- 2026-09-11
- Primary completion
- 2029-07-05
- Completion
- 2029-07-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Trospium | Small molecule | — | — |
| Subject | Xanomeline | Small molecule | — | — |